• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床口腔液样本中新型精神活性物质与传统滥用药物的流行病学研究。

Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples.

作者信息

Axelsson Magnus A B, Lövgren Hanna, Kronstrand Robert, Green Henrik, Bergström Moa Andresen

机构信息

Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Sahlgrenska University Hospital, Laboratory of Clinical Chemistry, Region Västra Götaland, Gothenburg, Sweden.

出版信息

Basic Clin Pharmacol Toxicol. 2025 Feb;136(2):e14117. doi: 10.1111/bcpt.14117.

DOI:10.1111/bcpt.14117
PMID:39806572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11730279/
Abstract

New psychoactive substances (NPS) are health-hazardous through unpredictable toxicity and effects and largely unknown epidemiology, motivating studies of the latter. Up to 138 NPS were retrospectively identified using liquid chromatography-high resolution mass spectrometry data from all 34 183 oral fluid drug samples collected in one Swedish health care region 2019-2020 representing 9468 psychiatric and addiction care patients. In total, 618 findings representing 58 NPS were detected in 481 samples from 201 patients. Male gender and age ≥25 years correlated positively with NPS use. Ketamine correlated positively with all NPS classes except cannabinoids; additionally, fentanyl, methadone, tapentadol and clonazepam correlated with multiple NPS classes. More numerous traditional drugs of abuse (DoA) correlated positively with sedative/hypnotic NPS, indicating that these are used in broader patient groups than other NPS. Mitragynine correlated negatively with other NPS in general and with several traditional DoA, but positively with the potential opioid abstinence remedies buprenorphine, loperamide and tapentadol aside from ketamine. In conclusion, NPS use is infrequent but occur also at higher ages, certain traditional DoA and particularly ketamine could have clinical value as NPS use signals, and mitragynine exhibited an atypical NPS consumption pattern indicating significant use as an opioid abstinence remedy.

摘要

新型精神活性物质(NPS)因其不可预测的毒性和影响以及很大程度上未知的流行病学情况而对健康有害,这促使人们对后者展开研究。利用液相色谱-高分辨率质谱数据,对2019年至2020年在瑞典一个医疗保健地区收集的所有34183份口腔液药物样本进行回顾性分析,共识别出多达138种NPS,这些样本代表了9468名精神科和成瘾护理患者。在来自201名患者的481份样本中,总共检测到618次NPS检出结果,涉及58种NPS。男性和年龄≥25岁与NPS使用呈正相关。氯胺酮与除大麻素类以外的所有NPS类别呈正相关;此外,芬太尼、美沙酮、曲马多和氯硝西泮与多种NPS类别相关。更多的传统滥用药物(DoA)与镇静/催眠NPS呈正相关,表明这些药物的使用患者群体比其他NPS更广泛。一般来说,帽柱木碱与其他NPS呈负相关,与几种传统DoA也呈负相关,但除氯胺酮外,与潜在的阿片类戒断药物丁丙诺啡、洛哌丁胺和曲马多呈正相关。总之,NPS的使用并不常见,但在较高年龄段也有发生,某些传统DoA尤其是氯胺酮可能具有作为NPS使用信号的临床价值,而帽柱木碱表现出非典型的NPS消费模式,表明其作为阿片类戒断药物有大量使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e042/11730279/13a833e987d0/BCPT-136-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e042/11730279/6ba3c6af39b3/BCPT-136-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e042/11730279/13a833e987d0/BCPT-136-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e042/11730279/6ba3c6af39b3/BCPT-136-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e042/11730279/13a833e987d0/BCPT-136-0-g003.jpg

相似文献

1
Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples.临床口腔液样本中新型精神活性物质与传统滥用药物的流行病学研究。
Basic Clin Pharmacol Toxicol. 2025 Feb;136(2):e14117. doi: 10.1111/bcpt.14117.
2
Prevalence of new psychoactive substances and drugs of abuse in the hair of individuals diagnosed with substance use disorder: Polydrug and emerging pattern of consumption.被诊断患有物质使用障碍的个体毛发中新精神活性物质和滥用药物的流行情况:多药使用及新出现的消费模式
J Forensic Sci. 2025 Mar;70(2):639-648. doi: 10.1111/1556-4029.15683. Epub 2024 Dec 10.
3
New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.通过综合高分辨率质谱尿液药物筛查揭示的新型精神活性物质作为阿片类药物维持治疗中多药滥用的一部分
Hum Psychopharmacol. 2016 Jan;31(1):44-52. doi: 10.1002/hup.2512. Epub 2016 Jan 13.
4
New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017.2017年法国西南部一场音乐节周边司机唾液中的新型精神活性物质
Forensic Sci Int. 2019 Apr;297:265-269. doi: 10.1016/j.forsciint.2019.02.029. Epub 2019 Feb 26.
5
Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS.液相色谱-串联质谱法检测唾液中的 104 种新型精神活性物质(NPS)及其他滥用药物。
J Anal Toxicol. 2020 Oct 12;44(7):697-707. doi: 10.1093/jat/bkaa089.
6
Validation and application of a method for the quantification of 137 drugs of abuse and new psychoactive substances in hair.验证和应用一种毛发中 137 种滥用药物和新型精神活性物质的定量方法。
J Pharm Biomed Anal. 2024 Jun 15;243:116054. doi: 10.1016/j.jpba.2024.116054. Epub 2024 Feb 17.
7
Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.2010 - 2014年瑞典涉及MDPV的中毒事件:STRIDA项目的结果
Clin Toxicol (Phila). 2015 Nov;53(9):865-73. doi: 10.3109/15563650.2015.1089576. Epub 2015 Oct 14.
8
Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017).新精神活性物质(NPS)和常规药物滥用(DOA)在来自巴黎(法国)及其郊区的高危人群中的流行情况:一项通过头发检测的横断面研究(2012-2017 年)。
Drug Alcohol Depend. 2019 Nov 1;204:107508. doi: 10.1016/j.drugalcdep.2019.06.011. Epub 2019 Aug 30.
9
Wastewater-based epidemiology to monitor 68 NPS/conventional drug use in Taipei metropolitan area in Taiwan during and after COVID-19 pandemic.基于污水的流行病学研究监测 COVID-19 大流行期间和之后台湾台北都会区 68 种新型精神活性物质/传统药物的使用情况。
J Hazard Mater. 2024 Sep 5;476:135020. doi: 10.1016/j.jhazmat.2024.135020. Epub 2024 Jun 29.
10
New psychoactive substances in oral fluid of French and Belgian drivers in 2016.2016 年法国和比利时司机唾液中的新型精神活性物质。
Int J Drug Policy. 2018 Jul;57:1-3. doi: 10.1016/j.drugpo.2018.03.013. Epub 2018 Apr 7.

引用本文的文献

1
Three Candidates, Two Peaks: Addressing Conflicting Assignments of Fentanyl Protomers with DMS-UVPD.三个候选物,两个峰:用DMS-UVPD解决芬太尼前体的矛盾归属问题
J Am Soc Mass Spectrom. 2025 Sep 3;36(9):1889-1901. doi: 10.1021/jasms.5c00130. Epub 2025 Jul 8.
2
The Role of Toxicology Investigations in Overdose Deaths.毒理学调查在过量用药死亡中的作用。
Cureus. 2025 Feb 20;17(2):e79352. doi: 10.7759/cureus.79352. eCollection 2025 Feb.

本文引用的文献

1
BCPT 2023 policy for experimental and clinical studies.BCPT 2023年实验与临床研究政策。
Basic Clin Pharmacol Toxicol. 2023 Oct;133(4):391-396. doi: 10.1111/bcpt.13944. Epub 2023 Sep 27.
2
Old Drugs and New Challenges: A Narrative Review of Nitazenes.老药与新挑战:硝氮烯类药物的叙述性综述
Cureus. 2023 Jun 21;15(6):e40736. doi: 10.7759/cureus.40736. eCollection 2023 Jun.
3
Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
2014年至2019年这六年期间,新型精神活性物质在欧洲药物紧急情况网络升级版(Euro-DEN plus)各急诊科的就诊情况。
Clin Toxicol (Phila). 2022 Dec;60(12):1318-1327. doi: 10.1080/15563650.2022.2137524. Epub 2022 Nov 2.
4
Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis.回顾性鉴定提交进行临床药物分析的患者样本中的新型精神活性物质。
Basic Clin Pharmacol Toxicol. 2022 Nov;131(5):420-434. doi: 10.1111/bcpt.13786. Epub 2022 Sep 5.
5
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature.**标题**:作为阿片类药物替代品的**Kratom**:危害还是危害减少?文献系统综述。
Am J Drug Alcohol Abuse. 2022 Sep 3;48(5):509-528. doi: 10.1080/00952990.2022.2111685. Epub 2022 Aug 24.
6
A New Strategy for Efficient Retrospective Data Analyses for Designer Benzodiazepines in Large LC-HRMS Datasets.一种在大型液相色谱-高分辨率质谱数据集里对设计型苯二氮䓬类药物进行高效回顾性数据分析的新策略。
Front Chem. 2022 May 19;10:868532. doi: 10.3389/fchem.2022.868532. eCollection 2022.
7
Trends in the Pharmaceutical Design of New Psychoactive Substances Detected in Oral Fluid OF Drivers Around a Music Festival in South-West France: Comparison 2019/2017.法国西南部音乐节期间驾驶人口腔液中新精神活性物质的药物设计趋势:2019 年与 2017 年的比较
Curr Pharm Des. 2022;28(15):1245-1249. doi: 10.2174/1381612828666220517160545.
8
Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis.分析确认存在精神活性物质,特别是新精神活性物质,在一组因使用精神活性物质导致精神和行为障碍而住院的患者中。
Int J Occup Med Environ Health. 2022 Aug 1;35(4):485-495. doi: 10.13075/ijomeh.1896.01863. Epub 2022 May 6.
9
An Update on the Implications of New Psychoactive Substances in Public Health.新精神活性物质对公共健康影响的最新研究进展。
Int J Environ Res Public Health. 2022 Apr 17;19(8):4869. doi: 10.3390/ijerph19084869.
10
Developments in high-resolution mass spectrometric analyses of new psychoactive substances.新型精神活性物质的高分辨率质谱分析进展。
Arch Toxicol. 2022 Apr;96(4):949-967. doi: 10.1007/s00204-022-03224-2. Epub 2022 Feb 9.